MC2 Therapeutics
Quick facts
Phase 2 pipeline
Phase 1 pipeline
- Challenge: Application of MC2-01 Cream, irradiation
- Challenge: Control, irradiation
- Clobetasol Propionate 0.05% Lotion
- Control, irradiation
- MC2-01 Cream, irradiation
- MC2-01 Cream, no irradiation
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: